TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34080544

Group type: EXPERIMENTAL
Intervention: Alcohol use disorder identification test
Number of subjects: 424

Group type: EXPERIMENTAL
Intervention: Chewing khat
Number of subjects: 424

Group type: EXPERIMENTAL
Intervention: Male sex
Number of subjects: 424

Group type: EXPERIMENTAL
Intervention: Having intimate friends who use alcohol
Number of subjects: 424

Group type: EXPERIMENTAL
Intervention: Being a 2nd year student
Number of subjects: 424

Group type: EXPERIMENTAL
Intervention: Being a 3rd year student
Number of subjects: 424

Group type: EXPERIMENTAL
Intervention: Being a 4th year student
Number of subjects: 424
Study: 33196555

Group type: EXPERIMENTAL
Intervention: COVID-19 related medical mistrust
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Negative COVID-19 impacts
Number of subjects: 101
Study: 32691272

Group type: EXPERIMENTAL
Intervention: Second Step Child Protection Unit (CPU)
Number of subjects: 1132
Study: 34965596

Group type: EXPERIMENTAL
Intervention: Counseling only (without HA)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Total masking (without HA)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Partial masking (without HA)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Counseling only (with HA)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Total masking (with HA)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Partial masking (with HA)
Number of subjects: 22
Study: 34743112

Group type: EXPERIMENTAL
Intervention: High-frequency, low-dose training
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 34879860

Group type: EXPERIMENTAL
Intervention: SPOC and TBL blended teaching model
Number of subjects: 52

Group type: COMPARATOR
Intervention: Conventional teaching method
Number of subjects: 52
Study: 35618860

Group type: EXPERIMENTAL
Intervention: Holmium-166 microspheres (166Ho-MS) administered after radiofrequency ablation (RFA)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Holmium-166 microspheres (166Ho-MS)
Number of subjects: 10
Study: 33402311

Group type: EXPERIMENTAL
Intervention: Recombinant human collagen hydrogel (RHCH)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Human-CTLA4-Ig gene-transferred pig skin xenotransplant
Number of subjects: 21
Study: 32820879

Group type: EXPERIMENTAL
Intervention: Calcipotriene/Betamethasone Dipropionate foam (Cal/BD foam) QD (Cal 0.005%, BD 0.064%)
Number of subjects: 408

Group type: COMPARATOR
Intervention: Calcipotriene foam (Cal foam) QD (Cal 0.005%)
Number of subjects: 408

Group type: COMPARATOR
Intervention: Betamethasone dipropionate foam (BD foam) QD (BD 0.064%)
Number of subjects: 408

Group type: EXPERIMENTAL
Intervention: Calcipotriene/Betamethasone Dipropionate foam (Cal/BD foam) QD
Number of subjects: 408

Group type: COMPARATOR
Intervention: Calcipotriene foam (Cal foam) QD
Number of subjects: 408

Group type: COMPARATOR
Intervention: Betamethasone dipropionate foam (BD foam) QD
Number of subjects: 408
Study: 33739982

Group type: EXPERIMENTAL
Intervention: Collaborative Stepped Care (CSC) intervention
Number of subjects: 1320

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 1320
Study: 34308589

Group type: EXPERIMENTAL
Intervention: Arthroscopic suture bridge technique
Number of subjects: 62

Group type: COMPARATOR
Intervention: Conventional double tunnel suture technique
Number of subjects: 62
Study: 32546045

Group type: EXPERIMENTAL
Intervention: Ibuprofen 10 mg/kg q6h and Acetaminophen 15 mg/kg q6h (4-hour dosing interval)
Number of subjects: 353

Group type: COMPARATOR
Intervention: Ibuprofen 10 mg/kg q6h and Acetaminophen 15 mg/kg q6h (increased dosing interval by 1 hour)
Number of subjects: 353
Study: 36076546

Group type: EXPERIMENTAL
Intervention: Naoqingzhiming tablet (180-2160 mg)
Number of subjects: 0
Study: 33794532

Group type: EXPERIMENTAL
Intervention: Hatha yoga (twice a week for 10 weeks)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Both groups (Hatha yoga and control)
Number of subjects: 31
Study: 35946912

Group type: EXPERIMENTAL
Intervention: Hesperidin (1g/day)
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Diosmin (1g/day)
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Combination of hesperidin and diosmin
Number of subjects: 129

Group type: COMPARATOR
Intervention: Oral hypoglycemics without intervention
Number of subjects: 129
Study: 33978907

Group type: EXPERIMENTAL
Intervention: enoxaparin 40 mg every 12 h (up to 50 mg every 12 h if repeat anti-Xa < 0.1 IU/mL)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: enoxaparin 30 mg every 8 h
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: enoxaparin 40 mg every 12 h
Number of subjects: 103

Group type: COMPARATOR
Intervention: Control group (anti-Xa ≥ 0.1 IU/mL)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Intervention group (anti-Xa < 0.1 IU/mL)
Number of subjects: 103
Study: 33212557

Group type: EXPERIMENTAL
Intervention: Open-lung strategy (OLS) with PEEP of 6-8 cm H2O and intermittent recruitment maneuvers (RM)
Number of subjects: 96

Group type: COMPARATOR
Intervention: NOLS group (without PEEP and RM)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Open-lung strategy (OLS)
Number of subjects: 96
Study: 32303447

Group type: COMPARATOR
Intervention: GLCM homogeneity (NL)
Number of subjects: 54

Group type: COMPARATOR
Intervention: GLCM contrast (NL)
Number of subjects: 54

Group type: COMPARATOR
Intervention: GLCM correlation (NL)
Number of subjects: 54

Group type: COMPARATOR
Intervention: GLCM dissimilarity (NL)
Number of subjects: 54

Group type: COMPARATOR
Intervention: GLCM energy (NL)
Number of subjects: 54

Group type: COMPARATOR
Intervention: GLCM entropy (NL)
Number of subjects: 54
Study: 32070326

Group type: EXPERIMENTAL
Intervention: Pre-operative assessment, information booklet, additional education, 30-min pulmonary rehabilitation training session, and post-operative pulmonary rehabilitation program
Number of subjects: 500

Group type: COMPARATOR
Intervention: Pre-operative assessment and information booklet
Number of subjects: 500
Study: 35943248

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 32866488

Group type: EXPERIMENTAL
Intervention: Allograft mixed with concentrated growth factor (CGF)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Allograft
Number of subjects: 10
Study: 33281065

Group type: EXPERIMENTAL
Intervention: FOLFOX4 (fluorouracil, leucovorin, oxaliplatin)
Number of subjects: 2145

Group type: EXPERIMENTAL
Intervention: FOLFIRI (fluorouracil, leucovorin, irinotecan)
Number of subjects: 2145
Study: 33095760

Group type: EXPERIMENTAL
Intervention: Preventive chemotherapy (PC) with albendazole, coverage ranging from 49% to 85%.
Number of subjects: 13552

Group type: COMPARATOR
Intervention: Not applicable (no control group mentioned).
Number of subjects: 13552
Study: 32529493

Group type: EXPERIMENTAL
Intervention: Rehabilitative treatment (12 sessions, 2/week)
Number of subjects: 59
Study: 32936951

Group type: EXPERIMENTAL
Intervention: Non-absorbable polytetrafluoroethylene mesh (CruraSoft®)
Number of subjects: 159

Group type: COMPARATOR
Intervention: Suture technique
Number of subjects: 159
Study: 35716107

Group type: EXPERIMENTAL
Intervention: Surgery+PDT
Number of subjects: 125

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 125
Study: 32236522

Group type: EXPERIMENTAL
Intervention: Mat Pilates Training (MPT)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 28
Study: 34862753

Group type: EXPERIMENTAL
Intervention: AST-120 (Renamezin®)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 150
Study: 33242918

Group type: EXPERIMENTAL
Intervention: Mother-role development program (2-year duration)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 120
Study: 35354682

Group type: EXPERIMENTAL
Intervention: Adductor canal block (ACB)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Intra-articular steroid-lidocaine injection (IASLI)
Number of subjects: 66
Study: 33326878

Group type: EXPERIMENTAL
Intervention: Trauma‐Informed Guilt Reduction (TrIGR) therapy
Number of subjects: 145

Group type: COMPARATOR
Intervention: Supportive Care Therapy (SCT)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: TrIGR therapy
Number of subjects: 145

Group type: COMPARATOR
Intervention: SCT
Number of subjects: 145
Study: 35436422

Group type: EXPERIMENTAL
Intervention: NaHCO3 + CAF
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: NaHCO3
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 34230526

Group type: EXPERIMENTAL
Intervention: Pinaverium 50 mg, three times daily for 4 weeks
Number of subjects: 264

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 264
Study: 34197780

Group type: EXPERIMENTAL
Intervention: Pharmacological dilation
Number of subjects: 889

Group type: COMPARATOR
Intervention: Control (untreated eyes)
Number of subjects: 889
Study: 33260253

Group type: EXPERIMENTAL
Intervention: Metronidazole (125 mg/mL) at 20 mg/kg PO q12h
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Metronidazole benzoate (25 mg/mL) at 20 mg/kg PO q12h
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Metronidazole benzoate (25 mg/mL) at 10 mg/kg PO q12h
Number of subjects: 12
Study: 34894707

Group type: EXPERIMENTAL
Intervention: Ischemic compression performed by family caregivers
Number of subjects: 75

Group type: COMPARATOR
Intervention: Sham ischemic compression
Number of subjects: 75

Group type: COMPARATOR
Intervention: Untreated control
Number of subjects: 75

Group type: COMPARATOR
Intervention: Ischemic compression and sham ischemic compression
Number of subjects: 75
Study: 35241363

Group type: EXPERIMENTAL
Intervention: One-on-one intervention consisting of six modules delivered via laptop computers
Number of subjects: 602
Study: 33565519

Group type: EXPERIMENTAL
Intervention: Targeted MRI/TRUS fusion prostate biopsy + systematic prostate biopsy (combined group)
Number of subjects: 161

Group type: COMPARATOR
Intervention: Systematic prostate biopsy (systematic group)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Targeted MRI/TRUS fusion prostate biopsy (in combined group)
Number of subjects: 161

Group type: COMPARATOR
Intervention: Systematic biopsy (in combined group)
Number of subjects: 161

Group type: COMPARATOR
Intervention: Systematic biopsies (in combined group)
Number of subjects: 161
Study: 34420532

Group type: EXPERIMENTAL
Intervention: IMPaCT therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 0
Study: 34292997

Group type: EXPERIMENTAL
Intervention: Exposed to riverbank erosion
Number of subjects: 611

Group type: COMPARATOR
Intervention: Non-exposed to riverbank erosion
Number of subjects: 611
Study: 32461105

Group type: EXPERIMENTAL
Intervention: Tucatinib (300 mg twice daily) in cohort A
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Tucatinib (750 mg once daily) in cohort B
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Overall (Tucatinib with trastuzumab)
Number of subjects: 41
Study: 35758002

Group type: EXPERIMENTAL
Intervention: ZNF582m/PAX1m test
Number of subjects: 424

Group type: COMPARATOR
Intervention: Liquid-based cytology (LBC)
Number of subjects: 424

Group type: EXPERIMENTAL
Intervention: ZNF582m
Number of subjects: 424

Group type: EXPERIMENTAL
Intervention: PAX1m
Number of subjects: 424
Study: 33687651

Group type: EXPERIMENTAL
Intervention: Chronic hypoparathyroidism
Number of subjects: 8097
Study: 35082253

Group type: EXPERIMENTAL
Intervention: Verum-nVNS
Number of subjects: 56

Group type: COMPARATOR
Intervention: Sham-nVNS
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: nVNS
Number of subjects: 56
Study: 34506972

Group type: EXPERIMENTAL
Intervention: Bumetanide treatment for 91 days
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 82
Study: 35064894

Group type: EXPERIMENTAL
Intervention: Biweekly monitoring/feedbacks (BMF)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Site-based assistance/mentorship (SAM)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Both BMF and SAM
Number of subjects: 81

Group type: COMPARATOR
Intervention: No intervention (Control)
Number of subjects: 81
Study: 33997964

Group type: EXPERIMENTAL
Intervention: Programa Compasso (PC)
Number of subjects: 3018
Study: 33686771

Group type: EXPERIMENTAL
Intervention: Laser treatment (Er:YAG and Nd:YAG lasers)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control group (standard extraction procedure)
Number of subjects: 53
Study: 36128833

Group type: EXPERIMENTAL
Intervention: Single-use flexible cystoscope (Ambu® aScopeTM️ 4 Cysto System)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Standard reusable flexible cystoscope (Olympus CYF‐VH)
Number of subjects: 101
Study: 35666208

Group type: EXPERIMENTAL
Intervention: SuperShelf intervention
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 11
Study: 33352006

Group type: EXPERIMENTAL
Intervention: Vacuum-formed space maintainer
Number of subjects: 30

Group type: COMPARATOR
Intervention: Banded space maintainer
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both vacuum-formed and banded space maintainers
Number of subjects: 30
Study: 35383908

Group type: EXPERIMENTAL
Intervention: Nivolumab (NIVO) plus ipilimumab (IPI) (3 mg/kg + 1 mg/kg every 3 weeks for 4 cycles)
Number of subjects: 1096

Group type: COMPARATOR
Intervention: Sunitinib (SUN) (50 mg daily for four 6-week cycles)
Number of subjects: 1096

Group type: EXPERIMENTAL
Intervention: Nivolumab (NIVO) plus ipilimumab (IPI)
Number of subjects: 1096

Group type: COMPARATOR
Intervention: Sunitinib (SUN)
Number of subjects: 1096
Study: 32891516

Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Ziprasidone
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 202

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 202
Study: 36297102

Group type: EXPERIMENTAL
Intervention: Caffeine (3 mg.kg−1)
Number of subjects: 22
Study: 33601687

Group type: EXPERIMENTAL
Intervention: Depression + PD
Number of subjects: 397

Group type: COMPARATOR
Intervention: Depression-only
Number of subjects: 397

Group type: EXPERIMENTAL
Intervention: PD ± depression
Number of subjects: 397
Study: 33934704

Group type: EXPERIMENTAL
Intervention: n‐3 LCPUFA (1 g/day, 694 mg DHA and 397 mg EPA)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Placebo (corn/soy oil blend)
Number of subjects: 600
Study: 33225970

Group type: EXPERIMENTAL
Intervention: Herbal extracts (Investigational Product - 1: 400mg, Investigational Product - 2: 450mg)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Herbal extracts (Investigational Product)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Investigational Product
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Liver Function Test and Kidney Function Test
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo (Edible starch 450mg)
Number of subjects: 72
Study: 35121606

Group type: EXPERIMENTAL
Intervention: 12-week specific exercise programme
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no exercise intervention)
Number of subjects: 100
Study: 32112263

Group type: EXPERIMENTAL
Intervention: Contact-based anti-stigma training
Number of subjects: 204
Study: 35282787

Group type: EXPERIMENTAL
Intervention: Fermented dairy beverage (8 oz containing 25-30 billion colony forming units of live and active kefir cultures)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Isocaloric, non-fermented, 1% low-fat lactose-free dairy-based control beverage (8 oz)
Number of subjects: 26
Study: 35914542

Group type: EXPERIMENTAL
Intervention: 5 mg tirzepatide
Number of subjects: 443

Group type: EXPERIMENTAL
Intervention: 10 mg tirzepatide
Number of subjects: 443

Group type: EXPERIMENTAL
Intervention: 15 mg tirzepatide
Number of subjects: 443

Group type: EXPERIMENTAL
Intervention: Tirzepatide (all doses)
Number of subjects: 443
Study: 32498226

Group type: EXPERIMENTAL
Intervention: Type 2 Diabetes Mellitus (T2DM) prevalence
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: High fasting blood glucose level
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: High glycosylated hemoglobin
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Age ≥ 50 years association with T2DM
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Educational level association with T2DM
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Nonconsumption of whole grains daily association with T2DM
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: High HOMA‐IR association with T2DM
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Correlation between BMI and glycemic parameters
Number of subjects: 150
Study: 35940465

Group type: EXPERIMENTAL
Intervention: Oral Itrifal Hakim Ali (IHA) (10g/day) and topical Habb‐e‐Kalaf (HK)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Oral Itraconazole (100 mg/day) and local Terbinafine (1%)
Number of subjects: 72
Study: 32933960

Group type: EXPERIMENTAL
Intervention: Behaviour Change Techniques (BCTs) in intervention groups
Number of subjects: 86

Group type: COMPARATOR
Intervention: Behaviour Change Techniques (BCTs) in control groups
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Most common BCTs in intervention groups
Number of subjects: 86

Group type: COMPARATOR
Intervention: Most common BCTs in control groups
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Identifiable BCTs
Number of subjects: 86
Study: 36691203

Group type: EXPERIMENTAL
Intervention: Public health education on iron and folic acid supplementation (IFAS)
Number of subjects: 1205
Study: 32665431

Group type: EXPERIMENTAL
Intervention: ERIC and/or SOFIA
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control devices
Number of subjects: 66
Study: 35682239

Group type: EXPERIMENTAL
Intervention: Cancer prevention program delivered by community health workers (CHWs); education by trained CHWs, telephone counseling once a month for 6 months, individual meetings, and CD-ROM with conversation scenarios.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group provided educational materials related to breast and cervical cancers and a booklet on mammography and Pap test.
Number of subjects: 0
Study: 32369545

Group type: EXPERIMENTAL
Intervention: Total dietary fibers (TDF)
Number of subjects: 107377

Group type: EXPERIMENTAL
Intervention: Soluble fibers (SF)
Number of subjects: 107377

Group type: EXPERIMENTAL
Intervention: Insoluble fibers (IF)
Number of subjects: 107377

Group type: EXPERIMENTAL
Intervention: Dietary fiber intake from fruit
Number of subjects: 107377
Study: 33542275

Group type: EXPERIMENTAL
Intervention: Probiotic (Ecologic Barrier)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 36427054

Group type: EXPERIMENTAL
Intervention: Sequential dual-task measures of listening effort with varying signal-to-noise ratios (SNR)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Self-reported listening effort
Number of subjects: 40
Study: 34851960

Group type: EXPERIMENTAL
Intervention: Cognitively demanding task to deplete self-control
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 0
Study: 613425329

Group type: EXPERIMENTAL
Intervention: Doxazosin 8 mg
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Ramipril 10 mg
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 61
Study: 35020250

Group type: EXPERIMENTAL
Intervention: Restylane (Group A) - Superficial injection (Group A1)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Restylane (Group A) - Deep injection (Group A2)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Yishumei (Group B) - Superficial injection (Group B1)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Yishumei (Group B) - Deep injection (Group B2)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Both fillers
Number of subjects: 100
Study: 32339059

Group type: EXPERIMENTAL
Intervention: Online social support messages
Number of subjects: 8343

Group type: EXPERIMENTAL
Intervention: Machine learning analysis of messages
Number of subjects: 8343
Study: 616119607

Group type: EXPERIMENTAL
Intervention: PASCAL laser PRP
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: EDTRS laser PRP
Number of subjects: 44

Group type: COMPARATOR
Intervention: IVR alone
Number of subjects: 44
Study: 35197212

Group type: EXPERIMENTAL
Intervention: Lower GNRI group (≤98)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Higher GNRI group (98<)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Combined model of GNRI and ARC‐HBR
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Lower GNRI and ARC‐HBR positivity
Number of subjects: 300
Study: 32412884

Group type: EXPERIMENTAL
Intervention: Energy Drink (ED) intake 15 minutes before exercise
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo protocol (PP) - water intake 15 minutes prior to exercise
Number of subjects: 29
Study: 36198322

Group type: EXPERIMENTAL
Intervention: Deep learning-based VMAT forward dose calculations using a convolutional neural network trained on dose of individual multi-leaf-collimator VMAT segments.
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Deep learning-based VMAT forward dose calculations on previously unseen IMRT patients.
Number of subjects: 17
Study: 34535091

Group type: EXPERIMENTAL
Intervention: Germicidal ultraviolet (GUV) light intervention
Number of subjects: 320

Group type: COMPARATOR
Intervention: Control (standard infection control measures)
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: GUV light intervention
Number of subjects: 320
Study: 33518152

Group type: EXPERIMENTAL
Intervention: Dietary arsenic supplementation (0.95, 20.78, 40.67, and 60.25 mg/kg)
Number of subjects: 512

Group type: EXPERIMENTAL
Intervention: Dietary arsenic supplementation
Number of subjects: 512
Study: 32041583

Group type: COMPARATOR
Intervention: Enhanced Care (EC) - SOC plus intensified TB case finding and active tracing
Number of subjects: 14963

Group type: COMPARATOR
Intervention: Enhanced Care plus Xpert (EC+X) - SOC plus intensified TB case finding, active tracing, and Xpert
Number of subjects: 14963

Group type: COMPARATOR
Intervention: Standard of Care (SOC) - no additional interventions
Number of subjects: 14963

Group type: COMPARATOR
Intervention: Comparison of EC+X to SOC
Number of subjects: 14963

Group type: COMPARATOR
Intervention: Comparison of EC+X to EC
Number of subjects: 14963
Study: 35366138

Group type: EXPERIMENTAL
Intervention: Kinesiotaping applied during 2 cycles for 2–3 weeks
Number of subjects: 16

Group type: COMPARATOR
Intervention: No specific therapy (control group)
Number of subjects: 16